Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Neuro-Oncology|February 14, 2012
Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcomeYongzhi Wang, Shouwei Li, Lingchao Chen, et al.
Frontiers in Oncology|August 2, 2021
Identification of the Prognostic Signatures of Glioma With Different <i>PTEN</i> StatusPei Zhang, Xinyi Meng, Liqun Liu, et al.
Brain Communications|May 20, 2024
Enrichment of oligodendrocyte precursor phenotypes in subsets of low-grade glioneuronal tumoursZejun Duan, Jing Feng, Yuguang Guan, et al.
Neuro-Oncology|May 10, 2012
miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expressionWei Zhang, Jing Zhang, Katherine Hoadley, et al.
Oncology Reports|September 3, 2011
Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathwaysYongzhi Wang, Lingchao Chen, Zhaoshi Bao, et al.
Oncotarget|September 4, 2016
Radiation combined with temozolomide contraindicated for young adults diagnosed with anaplastic gliomaPei Yang, Chuanbao Zhang, Jinquan Cai, et al.
Frontiers in Immunology|February 17, 2025
The clinical significance of T cell infiltration and immune checkpoint expression in central nervous system germ cell tumorsJiajun Zhou, Wenhao An, Lei Guan, et al.
Cancer|September 20, 2012
Whole-genome microRNA expression profiling identifies a 5-microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiformeWei Zhang, Jing Zhang, Wei Yan, et al.
Neuro-Oncology|March 2, 2024
Novel molecular subtypes of intracranial germ cell tumors expand therapeutic opportunitiesBo Li, Shuang Zhao, Shouwei Li, et al.
Oncotarget|October 28, 2015
IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registryPei Yang, Wei Zhang, Yinyan Wang, et al.
Pageof 7